Sale of 100 shares of Crowdstrike at the opening; Sale of 100 shares of DT at the opening; Purchase of 120 shares of CyberArk at the opening, Purchase of 40 shares of Datadog; Comments on the ZS downgrades As we discussed in the portfolio commentary we published yesterday, we are exiting our Crowdstrike position. The…
Sale of 250 shares of Nutanix; Sale of 100 shares of Dynatrace; purchase of 150 shares of AppLovin; Purchase of 20 shares of CyberArk We made some changes to the high growth portfolio today. In general, my strategy is to hold positions long term. But sometimes, when I see tactical opportunities, I take them. I…
Sale of 500 DT shares and purchase of 1000 shares of NU and 30 shares of Datadog We made some portfolio adjustments this morning. We sold 500 shares of Dynatrace at $47.79. We were not pleased with the company’s earnings report-particularly its forward guidance for ARR growth. After a couple of quarters of mentally making…
Dynatrace and Affirm – The opportunities are substantial I often tell subscribers and others that trying to trade earnings releases is a fool’s errand. I have tried to provide advice to a variety of clients for many years. I hope that I can share some of the experiences that I have had. An institutional sales…
Summary Dynatrace market shares gains are under-appreciated. It’s net new ARR growth last quarter was well above expectations. Its Grail offering has enabled the company to offer users functionality that is unavailable from competitors. The company has recently released security analytics for its observability platform, a boon for developers and deployed DT customers. The company…
Earnings season is taking on a roseate glow. Many companies are reporting upsides, quite a few are raising their forecasts. I mentioned in a recent article that bearishness amongst hedge fund managers in terms of the net short proportion of their portfolios had reached epic levels. Hedge fund managers, in my experience, are notorious for…
The last few days have seen a mini-rally in enterprise software stocks. I could tell readers that I was anticipating that, except for the fact that I have really been anticipating this since March, and most software stocks still have a long way to go before reclaiming those levels. At the most basic level, there…
What to make of the market in these days of tumult. I appreciate that some of the subscribers have offered encouragement and positive words to this analyst. But this hasn’t been an easy period to invest in the high-growth IT space. In fact, it hasn’t been a particularly easy period in which to invest in…
We initiated a position in the shares of Okta last fall at a price of $261. We believed that the merger with AuthO was underappreciated, and that the growth opportunity was substantial. In a way, that played out. But along the way, the shares were hugely rerated along with most other tech names. Then the…
Summary Dynatrace announced its fiscal Q3 results last week. The results were a beat on revenues and EPS and the company raised its guidance. The share price compressed as the result of controversy with regard to its growth of ARR. The growth of ARR, looked at carefully, was strong again, and adjusted properly exceeded 35%.…